Sundsvall Regional Hospital is one of three hospitals in the Västernorrland County. The hospital operates mainly in Sundsvall, but also in Härnösand, under joint hospital management. The hospital cooperates with other health care in the county, and the University Hospital of Umeå, Västerbotten County.

During the past decade, Sundsvall Hospital conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 2 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sundsvall Hospital" #1 sponsor was "Sundsvall Hospital" with 4 trials, followed by "Umeå University" with 4 trials sponsored, "Uppsala University" with 4 trials sponsored, "Karolinska Institutet" with 3 trials sponsored and "Jakob Wallden" with 3 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sundsvall Hospital" #1 collaborator was "Linkoeping University" with 3 trials as a collaborator, "Uppsala University" with 3 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Karolinska University Hospital" with 2 trials as a collaborator and "University Hospital, Linkoeping" with 2 trials as a collaborator. Other collaborators include 34 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "Sundsvall Hospital" are "Breast Cancer" (4 trials), "Multiple Myeloma" (3 trials), "Colorectal Cancer" (2 trials), "Lymphoma" (2 trials) and "Postoperative Complications" (2 trials). Many other conditions were trialed in "Sundsvall Hospital" in a lesser frequency.

Most popular intervention types in "Sundsvall Hospital" are "Drug" (17 trials), "Other" (9 trials), "Procedure" (9 trials), "Device" (5 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bortezomib" (2 trials), "Docetaxel" (2 trials), "Rituximab" (2 trials), "1 or 2 cycle(s) HDM (High Dose Melphalan)" (1 trials) and "2 cycles of Bortezomib, Lenalidomide, Dexamethasone (VRD)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sundsvall Hospital" are 32 trials for "All" genders and 5 trials for "Female" genders.

Currently, there are NaN active trials in "Sundsvall Hospital". undefined are not yet recruiting, 7 are recruiting, 5 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 21 completed trials in Sundsvall Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sundsvall Hospital, 1 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 13 trials that are defined as “Not Applicable".

Sundsvall Hospital has several departments that took part in Clinical trials: "Orthopaedic department, Sundsvall hospital" - 2 trials